4896 — K Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for K Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -229 | -391 | 301 | -844 |
| Depreciation | ||||
| Non-Cash Items | 9.63 | 36.7 | 64.9 | 7.6 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 16.4 | -9.67 | 88.4 | -147 |
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -196 | -363 | 454 | -984 |
| Capital Expenditures | — | -30 | -9.8 | -14.5 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -0.25 | -2.78 | -1.3 | — |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.25 | -32.7 | -11.1 | -14.5 |
| Financing Cash Flow Items | 0 | -0.09 | -10.1 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 368 | 1,544 | 1,486 | — |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 172 | 1,148 | 1,930 | -998 |